Satellite Symposia

SATELLITE SYMPOSIA

nAMD Treatment Fundamentals: Keys to a Proactive and Individualized Anti-VEGF Treatment Approach for nAMD Patients

9 September, 14:00 CEST

Chairperson(s): A. Loewenstein ISRAEL & N. Eter GERMANY

Details

Beyond VEGF: Targeting the Ang-Tie Pathway for the Management of Retinal Diseases

9 September, 18:45 CEST

Chairperson(s): P. Schlottmann ARGENTINA

Details

The Big Picture in Clinical Practice

10 September, 11:00 CEST

Chairperson(s): A. Loewenstein ISRAEL

Details

Clinical Perspectives on nAMD Management: Making Informed Decisions Along the Patient Journey

10 September, 11:00 CEST

Chairperson(s): A. Koh SINGAPORE

Details

Exploring New Retina Technologies and Beyond

10 September, 11:00 CEST

Chairperson(s): C. Mateo SPAIN

Details

Restoring Vision in Advanced AMD: A Roundtable Discussion on Treatment Options

10 September, 11:00 CEST

Chairperson(s): J. Talamo USA

Details

A Pathway to Enhanced Care for Inherited Retinal Dystrophy Patients

10 September, 14:00 CEST

Chairperson(s): B.P. Leroy BELGIUM

Details

The Ophthalmology Clinic of 2030: What is on the Horizon?

10 September, 14:00 CEST

Chairperson(s): M. de Smet SWITZERLAND

Details

AMD and DME Treatment Innovations: Home Monitoring, Artificial Intelligence Diagnostics and Extended Duration Anti-VEGF Therapeutics

10 September, 14:00 CEST

Chairperson(s): A. Loewenstein ISRAEL

Details

DME Management: Challenges and Opportunities

10 September, 18:00 CEST

Chairperson(s): T. Wong SINGAPORE

Details

Geographic Atrophy: What Have we Learnt and What is Still to be Discovered?

10 September, 18:00 CEST

Chairperson(s): F.G. Holz GERMANY

Details

Optimising nAMD Management Through Longer-acting Therapies

10 September, 18:00 CEST

Chairperson(s): A. Laidlaw UK

Details

Looking into the Future: nAMD Detection and Progression

10 September, 18:00 CEST

Chairperson(s): A. Loewenstein ISRAEL

Details

Controversies in Laser Treatments in 2021

10 September, 18:00 CEST

Chairperson(s): P. Stanga UK

Details

Digital Innovations: Jumping from Concepts to the Clinic

11 September, 11:00 CEST

Chairperson(s): N. Bressler USA

Details

Maximizing Treatment Benefits for our Patients with Retinal Vascular Diseases

11 September, 11:00 CEST

Chairperson(s): J. Kitchens USA

Details

Evolution in Surgical Techniques - The Modern VR Procedure

11 September, 11:00 CEST

Chairperson(s): R. Tadayoni FRANCE

Details

Best-informed Decision Making – Latest Innovations in Retinal Imaging and Surgical Visualization

11 September, 11:00 CEST

Chairperson(s): J.F Korobelnik FRANCE

Details

Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies

11 September, 14:00 CEST

Chairperson(s): R. Tadayoni FRANCE

Details

Flexibility and Long-term Predictability: Unlocking the Potential of Q16 Dosing for your Patients

11 September, 14:00 CEST

Chairperson(s): D. Wong CANADA

Details

Amgen: Spotlight on Real-world Considerations for Biosimilars in Ophthalmology

11 September, 14:00 CEST

Chairperson(s): J. Franklin USA

Details

AMD Fluid Resolution: Optimizing Real-world Outcomes in nAMD Treatment

11 September, 18:15 CEST

Chairperson(s): F.G. Holz GERMANY

Details

Register today

Registration for EURETINA 2021 Virtual is now open. Registration for Playback of EURETINA 2021 Virtual is open until 31 October 2021.

Member Registration Non-Member/ Group Registration